# Clinical trials recruiting in Bulgaria: 297 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 297 trials recruiting or not yet recruiting with a site in Bulgaria, as read on November 19, 2026.

## The full list

Clinical trials recruiting in Bulgaria: 297 rows for $14.85, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 5 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/country/bulgaria

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 297
- Recruiting or not yet: 297
- Read on: November 19, 2026

## Trials

The 25 newest of 297, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 12, 2026 | NCT07931599 | A Research Study Investigating How Well Zenagamtide at Lower Dose Levels Lowers Blood Sugar and Body Weight Compared to Semaglutide at... | Novo Nordisk A/S | Phase 3 | Not yet recruiting | Diabetes Mellitus, Type 2 | 1,060 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07931599) |
| November 12, 2026 | NCT07931573 | AMBITION 3: A Research Study Investigating How Well Zenagamtide at Higher Dose Levels Lowers Blood Sugar and Body Weight Compared to... | Novo Nordisk A/S | Phase 3 | Not yet recruiting | Type 2 Diabetes | 1,200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07931573) |
| November 12, 2026 | NCT07930949 | Injury Risks Among Acrobatic Gymnastics in Relation to Balance Training | Istanbul Galata University | Observational | Recruiting | Sports Injuries, Overuse Injuries, Acrobatic Gymnastics | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07930949) |
| November 10, 2026 | NCT07928245 | A Study of Brenipatide in Participants With Major Depressive Disorder | Eli Lilly and Company | Phase 2 | Not yet recruiting | Major Depressive Disorder | 330 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07928245) |
| November 5, 2026 | NCT07919405 | A Research Study to Investigate How Well the Medicine CagriSema Lowers High Blood Pressure in People Living With High Blood Pressure and... | Novo Nordisk A/S | Phase 3 | Not yet recruiting | Hypertension, Obesity | 1,408 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07919405) |
| November 4, 2026 | NCT07915219 | A Study to Learn How Well People With Bronchiectasis Tolerate Continued Treatment With Verducatib After Earlier Studies (AIRTIVITY®-ON) | Boehringer Ingelheim | Phase 3 | Not yet recruiting | Bronchiectasis | 1,500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07915219) |
| October 28, 2026 | NCT07900464 | The NUVASCULAR HARBOR Occlusion Device EU Study | Nuvascular Inc | Not applicable | Not yet recruiting | Intracranial Arterial Aneurysm | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07900464) |
| October 21, 2026 | NCT07885891 | Cefepime-Zidebactam Versus Ceftazidime-Avibactam With or Without Colistin for Hospital-Acquired or Ventilator-Associated Bacterial Pneumonia | Wockhardt | Phase 3 | Not yet recruiting | Hospital Acquired Bacterial Pneumonia (HABP), Ventilator Associated Bacterial Pneumonia (VABP) | 324 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07885891) |
| October 6, 2026 | NCT07861100 | A Research Study to Look at How Well Zenagamtide Works Compared to Placebo in People With Established Atherosclerotic Cardiovascular... | Novo Nordisk A/S | Phase 3 | Not yet recruiting | Cardiovascular Risk, Obesity | 8,500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07861100) |
| October 1, 2026 | NCT07851025 | Torvutatug Samrotecan Plus Bevacizumab as First-line Maintenance in Non-Homologous Recombination Deficiency (Non-HRD) Positive Advanced... | AstraZeneca | Phase 3 | Recruiting | Epithelial Ovarian Cancer | 950 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07851025) |
| September 30, 2026 | NCT07850453 | Vortosiran for VTE Prevention | Ribocure Pharmaceuticals AB | Phase 2 | Not yet recruiting | Venous Thromboembolism (VTE), Cancer, Pulmonary Embolism (Diagnosis) | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07850453) |
| September 3, 2026 | NCT07801573 | Immediate Molar Implants With Customized Healing Abutments in Different Post-Extraction Socket Classes | Plovdiv Medical University | Observational | Recruiting | Tooth Loss, Alveolar Bone Loss, Jaw, Edentulous, Partially | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07801573) |
| September 1, 2026 | NCT07797335 | AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People... | Novo Nordisk A/S | Phase 3 | Recruiting | Type 2 Diabetes, Cardiovascular Risk | 1,778 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07797335) |
| August 27, 2026 | NCT07789015 | A Study to Understand How Nerandomilast Works in People With Active Idiopathic Inflammatory Myopathies | Boehringer Ingelheim | Phase 3 | Not yet recruiting | Idiopathic Inflammatory Myopathies | 270 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07789015) |
| August 25, 2026 | NCT07784725 | A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2... | AstraZeneca | Phase 3 | Recruiting | Obesity or Overweight | 2,500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07784725) |
| August 24, 2026 | NCT07783282 | A Study to Learn How Enzalutamide, Apalutamide and Bicalutamide Affect the Way Fezolinetant is Processed in Men With Prostate Cancer | Astellas Pharma Global Development, Inc. | Phase 1 | Recruiting | Prostate Cancer | 56 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07783282) |
| August 18, 2026 | NCT07770841 | Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight | Novo Nordisk A/S | Phase 3 | Recruiting | Overweight, Obesity | 450 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07770841) |
| August 12, 2026 | NCT07761117 | A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF | AstraZeneca | Phase 3 | Recruiting | Heart Failure With Preserved Ejection Fraction (HFpEF), Heart Failure With Mildly Reduced Ejection Fraction (HFmrEF) | 6,950 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07761117) |
| August 10, 2026 | NCT07754240 | A Clinical Investigational Study of Ankura™ II AAA, IE and AE Stent Graft System for Endovascular Treatment of Abdominal Aortic Aneurysm | Lifetech Scientific (Shenzhen) Co., Ltd. | Not applicable | Recruiting | Abdominal Aortic Aneurysms (AAA) | 45 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07754240) |
| August 10, 2026 | NCT07753993 | A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease. | AstraZeneca | Phase 3 | Recruiting | Chronic Kidney Disease | 7,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07753993) |
| August 4, 2026 | NCT07743580 | A Study of Secutrelvir in Participants With Coronavirus Disease 2019 (COVID-19) Who Are at High Risk for Progression to Severe Disease | Shionogi | Phase 3 | Recruiting | SARS-CoV-2 | 2,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07743580) |
| August 3, 2026 | NCT07741656 | A Study of the Beacon Platform for Holmium Laser Enucleation of the Prostate (HoLEP) | Andromeda Surgical | Not applicable | Recruiting | BPH (Benign Prostatic Hyperplasia), HoLEP (Holmium Laser Enucleation of Prostate) | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07741656) |
| July 28, 2026 | NCT07731490 | Early Detection and IntervenTion in Heart Failure | University Hospital, Basel, Switzerland | Not applicable | Recruiting | Heart Failure (HF) | 18,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07731490) |
| July 22, 2026 | NCT07718828 | Laparoscopic Nissen Versus Toupet Fundoplication for Hiatal Hernia. | Sofia Med Hospital | Not applicable | Recruiting | Hiatal Hernia, Paraesophageal, Hiatal Hernia Large, Hiatal Hernia With Gastroesophageal Reflux Disease | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07718828) |
| July 17, 2026 | NCT07710144 | Innovative Mouthwash in School-Aged Children With Fixed Orthodontic Appliances | Plovdiv Medical University | Not applicable | Not yet recruiting | Plaque-Induced Gingivitis, Dental Plaque Accumulation, Halitosis | 90 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07710144) |

## Sites with the most of these trials

Sites as the records name them, organizations only.

| Site | City | Trials |
| --- | --- | --- |
| Medical Center Hera EOOD | Sofia | 22 |
| Medical Center Medconsult Pleven OOD | Pleven | 9 |
| Diagnostic Consultative Center Alexandrovska | Sofia | 6 |
| Medical Center Intermedica, OOD | Sofia | 5 |
| MBAL Uni Hospital | Panagyurishte | 5 |
| Diagnostic Consultative Center Aleksandrovska | Sofia | 5 |
| Acibadem City Clinic Tokuda University Hospital EAD | Sofia | 5 |
| MHAT Heart and brain | Pleven | 5 |
| Medical Center Hera - Kyustendil EOOD | Kyustendil | 4 |
| Medical Center Sveti Naum EOOD | Sofia | 4 |
| Medical Center Futuremeds | Plovdiv | 4 |
| Complex Oncology Center - Plovdiv EOOD | Plovdiv | 4 |
| Specialized Hospital for Active Treatment of Oncology - Haskovo | Haskovo | 4 |
| Complex Oncology Center - Ruse EOOD | Rousse | 4 |
| University Multiprofile Hospital for Active Treatment St. Ivan Rilski EAD | Sofia | 4 |
| Medical Center New Rehabilitation Center EOOD | Stara Zagora | 4 |
| Multiprofile Hospital MHATEM 'Pirogov', Sofia | Sofia | 4 |
| MHAT for Women's Health Nadezhda | Sofia | 4 |
| Diagnostic and Consultative Center Convex | Sofia | 4 |
| Medical Center Pulmo - 2018 EOOD | Haskovo | 4 |
| Medical Center Artmed | Plovdiv | 3 |
| Diamedical Medical Center 2013 | Dimitrovgrad | 3 |
| Ambulatory Individual Practice for Cardiology Specialized Medical Care | Pernik | 3 |
| Medical Center For Specialized Medical Help In Cardiovascular Diseases OOD | Sofia | 3 |
| ASOMHIDC - Individual practice "Cardio Tonus" EOOD | Sofia | 3 |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 1 | 15 |
| Phase 1/2 | 6 |
| Phase 2 | 52 |
| Phase 2/3 | 10 |
| Phase 3 | 178 |
| Phase 4 | 3 |
| Not applicable | 15 |
| Observational | 18 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Heart Failure | 16 |
| Obesity | 13 |
| Carcinoma, Non-Small-Cell Lung | 13 |
| Neoplasms | 9 |
| Depressive Disorder, Major | 9 |
| Crohn Disease | 9 |
| Diabetes Mellitus, Type 2 | 8 |
| Colitis, Ulcerative | 8 |
| Pulmonary Disease, Chronic Obstructive | 7 |
| Lupus Erythematosus, Systemic | 7 |
| Asthma | 7 |
| Overweight | 7 |
| Lung Neoplasms | 7 |
| Schizophrenia | 6 |
| Renal Insufficiency, Chronic | 6 |
| Hypertension | 5 |
| Alzheimer Disease | 5 |
| Breast Neoplasms | 5 |
| COVID-19 | 5 |
| Purpura, Thrombocytopenic, Idiopathic | 5 |
| Myelodysplastic Syndromes | 5 |
| Small Cell Lung Carcinoma | 5 |
| Atrial Fibrillation | 5 |
| Dermatomyositis | 4 |
| Cardiovascular Diseases | 4 |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| [AstraZeneca](https://specstream.ai/data/clinical-trials/company/astrazeneca) | 24 |
| [Pfizer](https://specstream.ai/data/clinical-trials/company/pfizer) | 16 |
| [Boehringer Ingelheim](https://specstream.ai/data/clinical-trials/company/boehringer-ingelheim) | 13 |
| [Novo Nordisk A/S](https://specstream.ai/data/clinical-trials/company/novo-nordisk-a-s) | 12 |
| [Novartis Pharmaceuticals](https://specstream.ai/data/clinical-trials/company/novartis-pharmaceuticals) | 11 |
| [Bristol-Myers Squibb](https://specstream.ai/data/clinical-trials/company/bristol-myers-squibb) | 10 |
| [AbbVie](https://specstream.ai/data/clinical-trials/company/abbvie) | 9 |
| [Takeda](https://specstream.ai/data/clinical-trials/company/takeda) | 8 |
| [Neurocrine Biosciences](https://specstream.ai/data/clinical-trials/company/neurocrine-biosciences) | 7 |
| [Hoffmann-La Roche](https://specstream.ai/data/clinical-trials/company/hoffmann-la-roche) | 7 |
| [Eli Lilly and Company](https://specstream.ai/data/clinical-trials/company/eli-lilly-and-company) | 6 |
| [Bayer](https://specstream.ai/data/clinical-trials/company/bayer) | 6 |
| [Intra-Cellular Therapies, Inc.](https://specstream.ai/data/clinical-trials/company/intra-cellular-therapies-inc) | 5 |
| [GlaxoSmithKline](https://specstream.ai/data/clinical-trials/company/glaxosmithkline) | 4 |
| [Karuna Therapeutics, Inc., a Bristol Myers Squibb company](https://specstream.ai/data/clinical-trials/company/karuna-therapeutics-inc-a-bristol-myers-squibb-company) | 4 |
| [Sanofi](https://specstream.ai/data/clinical-trials/company/sanofi) | 4 |
| [Chiesi Farmaceutici S.p.A.](https://specstream.ai/data/clinical-trials/company/chiesi-farmaceutici-s-p-a) | 3 |
| [Amgen](https://specstream.ai/data/clinical-trials/company/amgen) | 3 |
| [ACADIA Pharmaceuticals Inc.](https://specstream.ai/data/clinical-trials/company/acadia-pharmaceuticals-inc) | 3 |
| [Janssen Research & Development, LLC](https://specstream.ai/data/clinical-trials/company/janssen-research-and-development-llc) | 3 |
| [Merck Sharp & Dohme LLC](https://specstream.ai/data/clinical-trials/company/merck-sharp-and-dohme-llc) | 3 |
| [argenx](https://specstream.ai/data/clinical-trials/company/argenx) | 3 |
| [Genzyme, a Sanofi Company](https://specstream.ai/data/clinical-trials/company/genzyme-a-sanofi-company) | 3 |
| Climb Bio, Inc. | 2 |
| [Ascentage Pharma Group Inc.](https://specstream.ai/data/clinical-trials/company/ascentage-pharma-group-inc) | 2 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Tax preparation firms in the United States](https://specstream.ai/data/businesses/tax-preparation-firms/united-states)
- [B2B oil and gas exploration and development companies in the United States](https://specstream.ai/data/businesses/b2b-oil-and-gas-exploration-and-development-companies/united-states)
- [Doctors' offices in the United States](https://specstream.ai/data/businesses/doctors-offices/united-states)
- [Ice suppliers in the United States](https://specstream.ai/data/businesses/ice-suppliers/united-states)
- [Pediatric clinics in the United States](https://specstream.ai/data/businesses/pediatric-clinics/united-states)
- [Tea wholesalers in the United States](https://specstream.ai/data/businesses/tea-wholesalers/united-states)
